These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7357804)

  • 21. Conversion of supraventricular arrhythmias to sinus rhythm using flecainide.
    Goy JJ; Grbic M; Hurni M; Finci L; Maendly R; Duc J; Sigwart U
    Eur Heart J; 1985 Jun; 6(6):518-24. PubMed ID: 4043101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The proarrhythmic effects of flecainide.
    Nathan AW; Hellestrand KJ; Bexton RS; Spurrell RA; Camm AJ
    Drugs; 1985; 29 Suppl 4():45-53. PubMed ID: 4006779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Electrophysiological effects of the new antiarrhythmic drug flecainide (R 818) in man (author's transl)].
    Seipel L; Abendroth RR; Breithardt G
    Z Kardiol; 1981 Jul; 70(7):524-9. PubMed ID: 7269731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of flecainide in supraventricular arrhythmias].
    Chouty F; Leclercq JF; Coumel P
    Ann Cardiol Angeiol (Paris); 1986 Apr; 35(4):237-41. PubMed ID: 3740779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study of flecainide in the treatment of ventricular arrhythmia].
    Hug C; Koliopoulos N; Tardy C; Errera J; Puech P
    Ann Cardiol Angeiol (Paris); 1983 May; 32(3):161-4. PubMed ID: 6193751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the antiarrhythmic agent flecainide acetate on acute and chronic pacing thresholds.
    Hellestrand KJ; Burnett PJ; Milne JR; Bexton RS; Nathan AW; Camm AJ
    Pacing Clin Electrophysiol; 1983 Sep; 6(5 Pt 1):892-9. PubMed ID: 6195608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of intravenous flecainide on atrial vulnerability in man.
    Pop T; Treese N
    Drugs; 1985; 29 Suppl 4():1-6. PubMed ID: 4006774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of flecainide in the management of ventricular arrhythmias: comparative study with amiodarone.
    Dubner SJ; Elencwajg BD; Palma S; Mendelzon R; Ramos A; Bertolasi CA
    Am Heart J; 1985 Mar; 109(3 Pt 1):523-8. PubMed ID: 3883728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical usefulness of flecainide acetate in the treatment of paroxysmal supraventricular arrhythmias.
    Camm AJ; Hellestrand KJ; Nathan AW; Bexton RS
    Drugs; 1985; 29 Suppl 4():7-13. PubMed ID: 4006783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide.
    Duff HJ; Roden DM; Maffucci RJ; Vesper BS; Conard GJ; Higgins SB; Oates JA; Smith RF; Woosley RL
    Am J Cardiol; 1981 Dec; 48(6):1133-40. PubMed ID: 7304461
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of the efficacy of flecainide acetate in the treatment of ventricular premature contractions.
    Muhiddin KA; Turner P; Hellestrand K; Camm AJ
    Postgrad Med J; 1985 Jun; 61(716):489-96. PubMed ID: 2409543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistant ventricular arrhythmias treated with lorcainide, a new antiarrhythmic drug.
    Somani P; di Giorgi S
    Chest; 1980 Oct; 78(4):658-60. PubMed ID: 7418495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience in the long term use of new antiarrhythmic drugs.
    Meinertz T; Zehender MK; Geibel A; Treese N; Hofmann T; Kasper W; Pop T
    Drugs; 1985; 29 Suppl 4():26-7. PubMed ID: 4006777
    [No Abstract]   [Full Text] [Related]  

  • 35. Flecainide acetate for the treatment of atrial and ventricular arrhythmias.
    Apostolakis S; Oeff M; Tebbe U; Fabritz L; Breithardt G; Kirchhof P
    Expert Opin Pharmacother; 2013 Feb; 14(3):347-57. PubMed ID: 23294160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flecainide: one-year efficacy in patients with chronic ventricular arrhythmias.
    Vanhaleweyk G; Balakumaran K; Lubsen J; ten Cate FJ; Jovanovic A; Hagemeijer F; Withagen A; Polak BC; Roelandt J; Hugenholtz PG
    Eur Heart J; 1984 Oct; 5(10):814-23. PubMed ID: 6499854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerance of intravenous lorcainide in patients with normal and impaired intraventricular conduction.
    Stroobandt R; Kesteloot H
    Acta Cardiol; 1985; 40(6):637-48. PubMed ID: 3879420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flecainide: a new antiarrhythmic drug.
    Mueller RA; Baur HR
    Clin Cardiol; 1986 Jan; 9(1):1-5. PubMed ID: 3510788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flecainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
    Holmes B; Heel RC
    Drugs; 1985 Jan; 29(1):1-33. PubMed ID: 3882390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiarrhythmic therapy with flecainide in combination and comparison with propranolol.
    Stern H; Scheininger M; Theisen F; Theisen K
    Drugs; 1985; 29 Suppl 4():77-85. PubMed ID: 4006784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.